India: CCI- Chemists And Druggists Associations Warned To Refrain From Indulging Into Anti-Competitive Practices

In 2009, the Belgaum District Chemists and Druggists Association ('hereinafter referred as BCDA') filed a complaint alleging that Abbott India Ltd. and Geno Pharmaceuticals had stopped the supply of essential medicines. The sole ground for refusal by the Pharma Companies was that the members of the BCDA had to first obtain 'No objection certificate' from the All India organization of Chemists and Druggists ('hereinafter referred as AIOCD') or the Karnataka Chemists and Druggists Association ('hereinafter referred as KCDA') for being appointed as a stockist.

On 2nd March, 2017, the Competition Commission of India (hereinafter referred to as 'CCI') directed the KCDA to 'Cease and Desist' from indulging into the anti-competitive practice of mandating 'No Objection Certificate' as a prerequisite for appointment of stockist and also refrain from fixing 'trade margins' for retailers and wholesalers.1

Legal Scaffold-

According to Section 3 of the Competition Act, 2002 (hereinafter referred as the 'Act') no person shall enter into any agreement which shall have appreciable adverse effect upon competition in India and any such agreement entered into shall be held void.

Further, Section 3 (3) of the Act puts an embargo upon the practice of cartelisation that directly or indirectly affects purchase or sale prices, or limits demand, supply, production, development, etc. of any party to the agreement or any third party per se.

The CCI is empowered under Section 27 of the Act to issue any order or direction which it deems fit in cases of contravention of the provisions of Section 3. It is pertinent to note that for the purpose of determining whether an agreement is 'anti-competitive' the commission takes into account certain factors such as - creation of barriers to new entrants in the market; driving existing competitors out of the market; foreclosure of competition by hindering entry into the market; accrual of benefits to consumers; improvements in production or distribution of goods or provision of services; and so on.2

Brief facts of the case-

  • The BCDA was angered by the mandatory imposition of liability upon the stockists to have No Objection Certificates ('hereinafter referred as NOC') from AIOCD or KCDA due to which the supply of essential medicines was getting hampered. As a result in 2009, BCDA filed a complaint with the Director General of Investigation and Registration, Monopolies and Restrictive Trade Practices Commission (MRTP commission), which was later transferred to CCI.
  • Upon investigation by the Director General it was found that there was an understanding between AIOCD, the Indian Drug Manufactures Association and the Organisation of Pharmaceuticals Producers of India through a memorandum which laid out three things-

    1. The appointment of stockist was controlled by state association under the umbrella control of AIOCD;
    2. Trade margins of stockists and retailers was fixed; and
    3. There was a system of paid 'Product Information Service' which was provided to the pharmaceutical companies for the purpose of the advertisement of any new drug before introducing the product in the territory.
  • These practices were contended to have caused 'appreciable adverse effect' upon competition in the pharmaceutical industry in India as the practices limited and controlled the supply and prices of pharma products in the market.
  • AIOCD argued that the provision of mandatory NOC for the appointment of stockist is to protect consumers from spurious and fake drugs. Moreover, it justified the NOC norm by stating that it acted as a benchmark to ensure adequate quantity and quality of drugs in the market.
  • Furthermore, AIOCD replied that the fixation of trade margins ensure a level playing field, and to substantiate the statement it relied on the report of Dr. Kelkar Committee (1987) which recommended the fixation of trade margin with respect to wholesalers.

Findings-

  1. The CCI opined that the respondent to the present case have acted in contravention of Section 3(3)(a) and (b) of the 2002 Act by mandating NOC as a prerequisite for appointment of any new stockist of pharmaceutical products and fixing of trade margins for non-scheduled drugs.
  2. The contention of the respondents that the NOC practice was to keep a check on spurious drugs from unauthorized sources, was refused on the ground that such practice restricted the entry of new stockists and thereby limits the supply of medicines in the market. This position related to NOC was also confirmed by the Hon'ble Competition Appellate Tribunal in the case of All Kerala Chemists and Druggists vs. Competition Commission of India and Ors3. The Hon'ble Tribunal in the aforesaid case clarified that the requirement of NOC before the appointment of any stockist, not only limited the supply of drugs and medicines but also acted as an entry barrier, and therefore held the All Kerala Chemists and Druggists Association liable for default.
  3. The CCI concluded that the fixing of trade margins restricted price competition amongst wholesalers and amongst retailers in the market which in turn had adverse effect upon the consumers.
  4. With regard to the Product Information service charge levied upon the pharmaceutical companies for the introduction of a new drug in the market, there was no evidence to show that such a charge was mandatory. However, the CCI observed that imposition of a mandatory Product Information service charge would definitely be a restrictive trade practice.

Comments-

The Chemists and Druggists Associations have been working towards the regulation of pharmaceutical industry in India since decades. The respondents had relied on the excerpts from the report of Dr. Kelkar Committee (1987), which aimed to look into trade margin structure, that recommended that trade margins for wholesalers should be fixed after mutual discussion between trade and industry. However, the recommendations of the Dr. Kelkar Committee do not appear to be viable in view of the Competition Act coming into force. In a previous case4, the AIOCD and All Kerala Chemists and Druggists were held liable by the Commission for acting in contravention of Section 3 of the Act on the similar lines. In the case, the Commission imposed penalty on both the parties under Section 27(b) of the Act and also directed them to file an undertaking that the practices carried on by it such as the grant of NOC for appointment of stockist, fixation of trade margins, collection of Product Information service charges and boycott of products of pharmaceutical companies have been discontinued.

Footnotes

1 The Belgaum District Chemists and Druggists Association vs. Karnataka Chemists and Druggists Association and Ors- Case No. C-175/09/DGIR/27/28-MRTP

2 Section 19 (3) of the Competition Act 2002 

3 Appeal No. 17/2016

4 Case No. 30/2011- M/s. Peeveear Medical Agencies vs. Kerala and All India Organisation of Chemists and Druggists and others

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.